According to Joseph Ho, chief information officer at CGMH, the reduction of errors related to oral confirmation and manual entries of patient, medication and specimen ID data, as well as standard operating procedure compliance and real-time exception alerts, are major advantages of the system implementation.
Partnering with PDC, we were able to ensure the RFID system improved patient management and streamlined hospital procedures at CGMH.
CGMH will now further expand the use of these clinical diagnostics research platforms and will mirror the ClinProt solution at their hospital in Kaohsiung.
Sen-Yung Hsieh, Head of the Clinical Proteomics Laboratory at CGMH, commented: "We appreciate Bruker Daltonics' comprehensive analytical solutions approach, leading from sample preparation, via automation and mass spectrometry, to stream-lined data interpretation tools for workflows like profiling, biomarker analysis, SNP genotyping and in-depth protein analysis.
Wolfgang Pusch, Director of Clinical Proteomics and Biomarker Analysis Products at Bruker Daltonik GmbH, stated: "We are very pleased that the convincing performance of our already installed ClinProt systems at CGMH has led to further investments in new high-performance life-science mass spectrometry systems.
Shouldering a delivery rate of 1,500 babies every month, the OB/GYN staff at CGMH are constantly looking for ways to increase efficiency while improving overall care for its patients.
Yung-Kuei Soong, Vice Superintendent of CGMH, doctors find the solution far superior to paper-based records management and easier to use than previous electronic systems.
By using iConfigurator in this Internet-based solution, CGMH will be able to drastically reduce its reliance on paper-based records.